The latest study suggests that when paired with a triple-drug therapy, a ketogenic diet that is low in carbohydrates and protein and high in fat may help to destroy pancreatic cancer cells.
The study's findings were published in the journal 'Med.' The ketogenic diet decreased glucose (sugar) levels in tumours in laboratory trials, implying that the diet helped starve cancer. Additionally, this diet increased the amount of ketone bodies produced by the liver, putting additional strain on cancer cells. According to the study, by disrupting cancer cells, the ketogenic diet generated a microenvironment in which Tgen's triple-drug therapy (a mix of gemcitabine, nab-paclitaxel, and cisplatin) was more effective at eradicating the tumour.
"By reducing glucose availability, the ketogenic diet may enhance the efficiency of chemotherapy," TGen Distinguished Professor Professor Daniel D. Von Hoff, M.D., is widely regarded as one of the best authorities on pancreatic cancer in the United States. Dr Von Hoff is one of the study's authors and the therapy's creator.
Study finds Pioneering technique could unlock targeted treatments for cancer
Study finds a gene could prevent Parkinson's disease
Study finds Pollen season could be longer, more intense as climate changes